BWXT Names Jim J. Bittner Vice President and General Manager of Lynchburg, Virginia operations
(LYNCHBURG, Va. – March 15, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that Jim J. Bittner has been named Vice President and General Manager of the BWXT Nuclear Operations Group, Inc. (BWXT NOG) manufacturing facility in Lynchburg, Virginia. Bittner leads a workforce of approximately 2,200 employees in the manufacture of naval nuclear reactors […]
BWXT Awarded $35 Million in Uranium Processing and Research Reactor Fuel Contracts
(LYNCHBURG, Va. – March 11, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that its BWXT Nuclear Operations Group, Inc. (BWXT NOG) subsidiary has been awarded a total of $35 million in contracts under two separate programs – uranium recovery and conversion as well as construction of a new research reactor fuel line. “These […]
BWXT and GMS Form Joint Venture in Nuclear Medicine Manufacturing and Distribution in the Asia-Pacific Region
(LYNCHBURG, Va. – March 8, 2021) – BWXT Medical Ltd. (BWXT Medical) and Global Medical Solutions, Ltd. (GMS) have entered into a joint venture (JV) to manufacture and distribute radioisotopes and radiopharmaceuticals in the Asia-Pacific (Asia). BWXT Medical is a subsidiary of BWX Technologies, Inc. (NYSE: BWXT) and a global supplier of medical isotopes and […]
BWXT Subsidiary Awarded $57.5 Million Contract to Prepare for Uranium Conversion and Purification Services
(LYNCHBURG, Va. – March 1, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that its Nuclear Fuel Services, Inc. (NFS) subsidiary has received a $57.5 million contract from the National Nuclear Security Administration (NNSA) to prepare for future highly enriched uranium (HEU) conversion and purification services. Under this contract, NFS will provide a final […]
BWX Technologies Reports Solid Fourth Quarter 2020 Results, Marking New Annual Records for Revenue and Earnings and Achieves Long-Term Guidance
View the full report here.
BWXT Names Nuclear Medicine Business as BWXT Medical
(LYNCHBURG, Va. – Feb. 1, 2021) – BWX Technologies, Inc. (NYSE: BWXT) today announced that its subsidiary BWXT ITG Canada, Inc., a nuclear medicine company, has been renamed BWXT Medical Ltd. (BWXT Medical), in order to better align with the company’s products, customer base and strategy. BWXT’s entry into the nuclear medicine industry began with […]
BWXT Names Rob Smith President of Government Operations
LYNCHBURG, Va.–(BUSINESS WIRE)– BWX Technologies, Inc. (NYSE: BWXT) announced today Dr. Robert (Rob) F. Smith has been named to the newly created position of president of government operations, reporting to Rex Geveden, BWXT’s president and chief executive officer. In this position, Smith will be responsible for all of BWXT’s U.S.-based nuclear business lines that report […]